Hospira challenges patents on Cubist antibiotic – YAHOO!

LEXINGTON, Mass. (AP) — Cubist Pharmaceuticals Inc. said Thursday that Hospira Inc. is challenging the patents supporting its antibiotic Cubicin, which brings in almost all of Cubist’s revenue. Cubist said it will file a lawsuit against Hospira, alleging …